The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria
Open accessAbstract
Resistance to anticancer drugs is a problem in the treatment of pancreatic ductal carcinoma (PDAC) and overcoming it is an important issue. Recently, it has been reported that statins induce apoptosis in cancer cells but the mechanism has not been completely elucidated. We investigated the antitumor mechanisms of statins against PDAC and their impact on resistance to gemcitabine (GEM). Lovastatin (LOVA) increased mitochondrial oxidative stress in PDAC cells, leading to apoptosis. LOVA reduced lipid rafts in the plasma membrane and mitochondria, suppressed the activation of epithelial growth factor receptor (EGFR) and AKT in plasma membrane rafts, and reduced B-cell lymphoma 2 (BCL2)-Bcl-2-associated X protein (BAX) binding and the translocation of F1F0 ATPase in mitochondrial rafts. In the three GEM-resistant cell lines derived from MIA and PANC1, the lipid rafts in the cell membrane and the mitochondria were increased to activate EGFR and AKT and to increase BCL2-BAX binding, which suppressed apoptosis. LOVA abrogated these anti-apoptotic effects by reducing the rafts in the resistant cells. By treating the resistant cells with LOVA, GEM sensitivity improved to the level of the parental cells. Therefore, cholesterol rafts contribute to drug resistance in PDAC. Further clinical research is warranted on overcoming anticancer drug resistance by statin-mediated intracellular cholesterol regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gyoten et al. observed, in three gemcitabine-resistant PDAC cell lines, an increased activity of the epidermal growth factor receptor (EGFR)-Akt axis, which in turn increased the binding of B-cell lymphoma 2 (BCL2)-Bcl-2-associated X protein (BAX), thus suppressing apoptosis.”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Gyoten et al., 2023
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A convergent mechanism identified across multiple studies is the disruption of plasma membrane lipid rafts by statins through intracellular cholesterol depletion (Duranti et al., 2025; Gyoten et al., 2023).”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Gyoten et al., 2023
The cited source says what the claim attributes to it.
In the citing paper
“This effect was countered by the lovastatin treatment, by disrupting the lipid rafts in the cell and mitochondria membranes, and by increasing mitochondrial oxidative stress (Gyoten et al., 2023).”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Gyoten et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Park, W., Chawla, A., & O’Reilly, E. M. (2021) · JAMA · doi:10.1001/jama.2021.13027 · Cited by 1,882
Hyperlipidemia as a Risk Factor for Cardiovascular Disease
Nelson, R. H. (2013) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2012.11.003 · Cited by 1,093
Bax, Bak and beyond — mitochondrial performance in apoptosis
Peña‐Blanco, A., & García‐Sáez, A. J. (2018) · The FEBS Journal · doi:10.1111/febs.14186 · Cited by 930
Statins: mechanism of action and effects
Stancu, C., & Sima, A. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00172.x · Cited by 911 · cited 1×
“Statins inhibit the rate-limiting reaction of cholesterol synthesis in which 3-hydroxy-3-methylglutaryl coenzyme A (HMGC) is converted to mevalonate by HMGC reductase [14].”
BackgroundChemoresistance in Pancreatic Cancer
Zeng, S., Pöttler, M., Lan, B., Grützmann, R., Pilarsky, C., & Yang, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184504 · Cited by 611
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Sherman, M. H., & Beatty, G. L. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031621-024600 · Cited by 467
Oxidative Stress, Redox Signaling, and Autophagy: Cell Death Versus Survival
Navarro-Yepes, J., Burns, M., Anandhan, A., Khalimonchuk, O., del Razo, L. M., Quintanilla-Vega, B., Pappa, A., Panayiotidis, M. I., & Franco, R. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5837 · Cited by 449
Statins: a repurposed drug to fight cancer
Jiang, W., Hu, J.-W., He, X.-R., Jin, W.-L., & He, X.-Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02041-2 · Cited by 417
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Binenbaum, Y., Na’ara, S., & Gil, Z. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.002 · Cited by 414
Cited by
Oyón, D., López-Pascual, A., Castelló-Uribe, B., Uriarte, I., Orsi, G., Llorente, S., Elurbide, J., Adán-Villaescusa, E., Valbuena-Goiricelaya, E., Irigaray-Miramon, A., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03268-5 · Cited by 26
Karthikeyan, S., Somasundaram, P., Karimi, I., Lagunas‐Rangel, F. A., Alsehli, A. M., Fredriksson, R., Jonsson, J., & Schiöth, H. B. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107912 · Cited by 26
Caveolae: Metabolic Platforms at the Crossroads of Health and Disease
Stea, D. M., & D’Alessio, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072918 · Cited by 21
Zabielska, J., Stelmańska, E., Szrok-Jurga, S., Kobiela, J., & Czumaj, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031186 · Cited by 14
Li, W., Xu, J., Long, Y., Zhang, H., Rong, X., & Su, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101945 · Cited by 10
Metadata
- Authors
- Gyoten, M., Luo, Y., Fujiwara-Tani, R., Mori, S., Ogata, R., Kishi, S., & Kuniyasu, H.
- Affiliations
- Nara Medical University (JP)
- Nantong University (CN)
- Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan
- Nozaki Tokushukai Hospital (JP)
- Corresponding author
- Kuniyasu, Hiroki
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-11-27
- Volume
- 24
- Issue
- 23
- Pages
- 16814
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10706654
- OpenAlex
- W4389048098
- Cited by
- 28
- References
- 40
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 3
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- MEXT KAKENHI (19K16564, 20K21659, 23K16621, 23K19900)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Keywords
- lovastatin, statins, pancreatic ductal carcinoma, apoptosis, lipid rafts, gemcitabine resistance, mitochondrial oxidative stress, EGFR, Akt, chemoresistance
- MeSH terms
- Gemcitabine, Antineoplastic Agents, Cell Membrane, Cholesterol, Humans, Lovastatin, Mitochondria, Pancreatic Neoplasms, Apoptosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Carcinoma, Pancreatic Ductal, Membrane Microdomains, Cell Line, Tumor, bcl-2-Associated X Protein, Proto-Oncogene Proteins c-akt, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria. https://app.cochat.ai/papers/10.3390/ijms242316814
- The paper
- Gyoten, M., Luo, Y., Fujiwara-Tani, R., Mori, S., Ogata, R., Kishi, S., & Kuniyasu, H. (2023). Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316814
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.